-
Howard Hughes Medical Institute - Tue Dec 8, 12:06 pm ET
Scientists have discovered a new type of stem cell in the skin that acts surprisingly like certain stem cells found in embryos: both can generate fat, bone, cartilage, and even nerve cells.
-
Business Wire via Yahoo! Finance - Tue Dec 8, 10:48 am ET
NEW YORK----In a statement today, StemSave, Inc., the market leader in the field of stem cell recovery and cryo-preservation lauds research published in the November issue of the European Cells and Materials Journal citing the reconstruction of the human mandible bone with autologous dental pulp stem cells.
-
PR Newswire via Yahoo! Finance - Tue Dec 8, 7:00 am ET
ST. JOSEPH, Mich. , Dec. 8 /PRNewswire/ -- GeneGo, Inc., the leading systems biology tools company, announced today that Millipore Corporation has sponsored academic groups from University of Queensland , Sheffield and USC to become members of the collaborative MetaMiner (Stem Cells) project run by GeneGo. Â MetaMiner is a partnership program for the reconstruction of stem cell pathways and ...
-
HealthDay via Yahoo! News - Tue Dec 8, 2:03 pm ET
TUESDAY, Dec. 8 (HealthDay News) -- New research has found that a certain kind of stem cell from human umbilical cords helped restore transparency to the cloudy corneas of laboratory mice, raising the prospect that they could do the same for people.
-
Science Daily - Tue Dec 8, 4:09 pm ET
The second phase of a clinical trial testing a new stem-cell-based therapy on injured heart muscle has been launched by researchers at the University of Texas Medical School at Houston.
-
The Cincinnati Enquirer - Tue Dec 8, 4:58 pm ET
University of Cincinnati researchers used human stem cells to heal damaged corneas in mice.
-
Park Hills Daily Journal - Tue Dec 8, 1:19 pm ET
WASHINGTON (AP) — Scientists can start using taxpayer dollars to do research with 13 batches of embryonic stem cells and the government says dozens more cell lines should be available soon, opening a new era for the potentially life-saving field.
-
GenomeWeb News - Tue Dec 8, 10:00 am ET
NEW YORK (GenomeWeb News) – GeneGo said today that Millipore has sponsored academic groups from the Universities of Queensland, Sheffield, and Southern California to become members of the GeneGo's collaborative MetaMiner stem cells project.
-
redOrbit - Tue Dec 8, 1:08 pm ET
Curcumin, piperine could play role in preventing breast cancerA new study finds that compounds derived from the spices turmeric and pepper could help prevent breast cancer by limiting the growth of stem cells, the small number of cells that fuel a tumor’s growth.Researchers at the University of Michigan Comprehensive Cancer Center have found that when the dietary compounds curcumin, which is ...
-
EurekAlert! - Tue Dec 8, 10:35 am ET
( Cedars-Sinai Medical Center ) The Cedars-Sinai Regenerative Medicine Institute is to provide stem cells to a five-member National Institutes of Health consortium of researchers for development of potential therapies to treat Huntington's disease.
-
TV 7&4 Traverse City - Tue Dec 8, 8:17 am ET
Researcher speaks in Detroit on the status of stem cell research
-
WXYZ-TV Detroit - Tue Dec 8, 7:50 am ET
A leading researcher and director of University of Michigan's A. Alfred Taubman Medical Research Institute will speak in Detroit on the status of stem cell research and its promises of...
-
FOX 2 News Detroit - Tue Dec 8, 7:12 am ET
A leading researcher and director of University of Michigan's A. Alfred Taubman Medical Research Institute will speak in Detroit on the status of stem cell research and its promises of improving health and the economy.
-
Science Daily - Mon Dec 7, 2:39 pm ET
The methods and outcomes for stem cell transplants are constantly improving as leading experts continue to investigate new approaches for reducing the serious adverse events associated with the procedure. New research takes a closer look at complications of stem cell transplants, including veno-occlusive disease and graft-versus-host disease.
-
The Emory Wheel - Mon Dec 7, 9:59 pm ET
Emory plans to conduct the first U.S. clinical trial to implant stem cells into the spinal cords of adults with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, beginning in January.
